News >

ASCO Names Refinement of Surgical Treatment of Cancer as Advance of the Year

Kristi Rosa
Published: Tuesday, Feb 04, 2020

Howard A. Burris, III, MD, FACP, FASCO, chief medical officer and president of Clinical Operations at Sarah Cannon Research Institute

Howard A. "Skip" Burris, III, MD, FACP, FASCO

Following significant progress made in the development of novel systemic therapies for patients with cancer, the role of surgery in oncology continues to evolve. To this end, ASCO has selected the refinement of surgical treatment of cancer as its Advance of the Year.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x